Talactoferrin alfa
Talactoferrin alfa | |
---|---|
Term | Talactoferrin alfa |
Short definition | talactoferrin alfa - (pronounced) (tuh-LAK-toh-FAYR-in AL-fuh) drug being studied to treat spreading kidney cancer. It is also being studied in the treatment of other types of cancer and other conditions. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
talactoferrin alfa - (pronounced) (tuh-LAK-toh-FAYR-in AL-fuh) drug being studied to treat spreading kidney cancer. It is also being studied in the treatment of other types of cancer and other conditions. Talactoferrin alfa increases the activity of dendritic cells (a type of immune cell) to kill cancer cells. It's a form of human lactoferrin (a protein found in milk, tears, mucus, bile, and some white blood cells) that's made in the laboratory. Talactoferrin alfa is a type of recombinant protein and a type of immunomodulatory protein. Also called talactoferrin and TLF
External links
- Medical encyclopedia article on Talactoferrin alfa
- Wikipedia's article - Talactoferrin alfa
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski